Older-Adult Deprescribing Review Found Sparse Evidence Specifically in Cognitive Impairment

An intervention literature dominated by general older-adult samples does not automatically establish effectiveness in dementia.

What the publication shows

The systematic review included seventeen reports describing sixteen studies of patient-directed benzodiazepine-receptor-agonist deprescribing interventions. Education and multicomponent approaches produced widely varying cessation rates. Only one report specifically examined an educational intervention in participants with cognitive impairment.

Limits of the evidence

Most studies had high risk of bias. Interventions, settings and outcomes differed, making a simple ranking of success percentages misleading. Cessation, dose reduction, sleep outcomes and withdrawal safety are separate endpoints; evidence for one cannot substitute for the others.

Application to expert review

For a care-plan assessment, identify cognitive status, caregiver involvement, comprehension and follow-up arrangements. Avoid assuming that a leaflet alone has established effectiveness for every cognitively impaired patient. The review supports education as a component while showing the limitations of subgroup evidence.

Source and related reading

Source: Publication PMC12460949. The case-review applications above are interpretive analysis.